P
PASG
Passage Bio, Inc.
7.48
-0.07-0.86%After Hours: 7.25 -0.23 -3.01%17:59 08/25 EDT
OPEN/PREV CLOSE7.70/7.54
TODAY RANGE7.24-7.70
VOL16.34K
MARKET CAP23.76M
52 WEEK RANGE5.12-26.60
AVG VOL (3M)50.67K
% TURNOVER0.51%
TURNOVER--
P/E (TTM)-0.4085
% RANGE6.10%
EPS(TTM)-18.2990
P/E(FORWARD)-0.5597
P/B0.6211
BVPS12.04
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP22.72M
SHARES OUTSTANDING3.18M
NEXT EARNINGS11/11-11/17
FREE FLOAT3.04M
LOT SIZE1
EX-DATE07/14/2025
News
Press Releases
Financial Reports
Profile
Dow Jones·08/14 16:39
Passage Bio Price Target Cut to $67.00/Share From $260.00 by Canaccord Genuity
Dow Jones·08/14 16:39
Passage Bio Is Maintained at Buy by Canaccord Genuity
Benzinga·08/14 16:30
Canaccord Genuity Maintains Buy on Passage Bio, Lowers Price Target to $67
TipRanks·08/14 15:15
Passage Bio (PASG) Receives a Buy from Guggenheim
Dow Jones·08/14 13:53
Passage Bio Price Target Cut to $10.00/Share From $40.00 by Guggenheim
Dow Jones·08/14 13:53
Passage Bio Is Maintained at Buy by Guggenheim
Benzinga·08/14 13:43
Guggenheim Maintains Buy on Passage Bio, Lowers Price Target to $10
TipRanks·08/14 13:25
Passage Bio price target lowered to $67 from $260 at Canaccord
TipRanks·08/13 18:16
Passage Bio (PASG) Receives a Buy from TD Cowen
Dow Jones·08/13 14:55
Passage Bio Price Target Raised to $40.00/Share From $3.00 by Wedbush
Dow Jones·08/13 14:55
Passage Bio Is Maintained at Outperform by Wedbush
Benzinga·08/13 14:45
Wedbush Maintains Outperform on Passage Bio, Raises Price Target to $40
Same Industry
Name/Symbol
Change%
Price